Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/19918
Title: | SOCS2 polymorphisms are not associated with clinical and biochemical phenotypes in acromegalic patients |
Authors: | TRARBACH, Ericka B.; JORGE, Alexander A.; DUARTE, Felipe H.; BRONSTEIN, Marcello D.; JALLAD, Raquel S. |
Citation: | PITUITARY, v.20, n.3, p.319-324, 2017 |
Abstract: | Purpose Suppressor of cytokine signaling 2 (SOCS2) is a STAT5b-regulated gene and one of its functions is to influence growth and development through negative regulatory effects on GH/IGF-1 pathway. So, we evaluate the potential influence of SOCS2 single nucleotide polymorphisms (SNPs) on clinical and laboratorial characteristics of a large cohort of Brazilian patients with acromegaly. Methods Four SOCS2 SNPs (rs3782415, rs3816997, rs3825199 and rs11107116) were selected and genotyped by real-time PCR using specific Taqman probe assays. A total of 186 patients (116 women, age range 26-88 years) were evaluated. Results No association of SOCS2 genotypes was observed with none of the following clinical and laboratorial characteristics: age, sex, body mass index, comorbidities, basal GH, oral glucose tolerance test GH nadir, IGF-I, ULNRIGF-I. Conclusion Despite of the key role of SOCS2 in the regulation of GH receptor signaling, we did not find any significant association between SOCS2 polymorphisms and acromegaly. |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCM Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/25 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_TRARBACH_SOCS2_polymorphisms_are_not_associated_with_clinical_and_2017.PDF Restricted Access | publishedVersion(English) | 344.09 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.